AstraZeneca shares dip after $39 bln Alexion deal
Вставка
- Опубліковано 13 гру 2020
- AstraZeneca shares fell on Monday, as investors moved to price in the British drugmaker's $39 billion deal for U.S. biotech firm Alexion Pharmaceuticals, the company's largest ever takeover and one of this year's biggest mergers globally.
Subscribe: smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: reuters.com/
Follow Reuters on Facebook: / reuters
Follow Reuters on Twitter: / reuters
Follow Reuters on Instagram: reuters?hl=en
